|
AR095196A1
(es)
|
2013-03-15 |
2015-09-30 |
Regeneron Pharma |
Medio de cultivo celular libre de suero
|
|
JO3701B1
(ar)
*
|
2014-05-23 |
2021-01-31 |
Regeneron Pharma |
مضادات حيوية بشرية لمتلازمة الشرق الأوسط التنفسية - بروتين كورونا فيروس الشوكي
|
|
TW201628649A
(zh)
|
2014-10-09 |
2016-08-16 |
再生元醫藥公司 |
減少醫藥調配物中微可見顆粒之方法
|
|
TW202440903A
(zh)
|
2015-08-04 |
2024-10-16 |
美商再生元醫藥公司 |
補充牛磺酸之細胞培養基及用法（一）
|
|
CN106928326B
(zh)
*
|
2015-12-31 |
2019-12-24 |
中国科学院微生物研究所 |
一种基于二聚化的受体结合区亚单位的冠状病毒疫苗
|
|
US11542332B2
(en)
|
2016-03-26 |
2023-01-03 |
Bioatla, Inc. |
Anti-CTLA4 antibodies, antibody fragments, their immunoconjugates and uses thereof
|
|
CN107298712B
(zh)
*
|
2016-04-14 |
2020-04-07 |
中国疾病预防控制中心病毒病预防控制所 |
全人源化抗中东呼吸综合征冠状病毒中和抗体
|
|
TW201815821A
(zh)
*
|
2016-07-18 |
2018-05-01 |
美商再生元醫藥公司 |
抗茲卡病毒抗體及使用方法
|
|
SG11201900201YA
(en)
|
2016-08-16 |
2019-02-27 |
Regeneron Pharma |
Methods for quantitating individual antibodies from a mixture
|
|
EP3504328A1
(en)
|
2016-08-24 |
2019-07-03 |
Regeneron Pharmaceuticals, Inc. |
Host cell protein modification
|
|
AU2017350807B2
(en)
|
2016-10-25 |
2022-07-07 |
Regeneron Pharmaceuticals, Inc. |
Methods and systems for chromatography data analysis
|
|
KR20180058206A
(ko)
*
|
2016-11-23 |
2018-05-31 |
에스케이케미칼 주식회사 |
중동호흡기증후군 코로나바이러스 s 단백질 면역원 조성물 및 이의 제작 방법
|
|
CN118140872A
(zh)
*
|
2017-01-19 |
2024-06-07 |
欧莫诺艾比公司 |
来自具有多个重链免疫球蛋白基因座的转基因啮齿类动物的人抗体
|
|
TW201902896A
(zh)
|
2017-05-22 |
2019-01-16 |
瑞士商赫孚孟拉羅股份公司 |
治療化合物及組合物及其使用方法
|
|
EP3967765A1
(en)
|
2017-07-06 |
2022-03-16 |
FrieslandCampina Nederland B.V. |
Cell culture process for making a glycoprotein
|
|
KR101895228B1
(ko)
*
|
2017-08-23 |
2018-10-30 |
대한민국 |
중동호흡기증후군 코로나바이러스의 스파이크 단백질에 대한 단일클론항체 및 이의 용도
|
|
CN118416215A
(zh)
|
2017-09-19 |
2024-08-02 |
里珍纳龙药品有限公司 |
减少粒子形成的方法以及由其形成的组合物
|
|
WO2019067671A1
(en)
*
|
2017-09-27 |
2019-04-04 |
David Weiner |
DNA ANTIBODY CONSTRUCTS FOR USE IN CORONAVIRUS RESPIRATORY SYNDROME OF THE MIDDLE EAST
|
|
KR102017217B1
(ko)
*
|
2017-10-19 |
2019-09-02 |
주식회사 엔케이맥스 |
중동호흡기증후군 코로나바이러스에 대한 항체 및 이를 이용한 항체역가 측정방법
|
|
WO2019126123A1
(en)
|
2017-12-22 |
2019-06-27 |
Regeneron Pharmaceuticals, Inc. |
System and method for characterizing drug product impurities
|
|
KR20190093107A
(ko)
*
|
2018-01-31 |
2019-08-08 |
(주)셀트리온 |
중동호흡기증후군 코로나바이러스에 중화활성을 갖는 결합 분자
|
|
WO2019151632A1
(ko)
*
|
2018-01-31 |
2019-08-08 |
(주)셀트리온 |
중동호흡기증후군 코로나바이러스에 중화활성을 갖는 결합 분자
|
|
AU2019215363A1
(en)
|
2018-01-31 |
2020-07-23 |
Regeneron Pharmaceuticals, Inc. |
System and method for characterizing size and charge variant drug product impurities
|
|
TW202311746A
(zh)
|
2018-02-02 |
2023-03-16 |
美商再生元醫藥公司 |
用於表徵蛋白質二聚合之系統及方法
|
|
KR20200127979A
(ko)
|
2018-02-28 |
2020-11-11 |
리제너론 파마슈티칼스 인코포레이티드 |
바이러스 오염물질을 확인하기 위한 시스템 및 방법
|
|
US12259355B2
(en)
|
2018-03-19 |
2025-03-25 |
Regeneron Pharmaceuticals, Inc. |
Microchip capillary electrophoresis assays and reagents
|
|
EP4317959A3
(en)
|
2018-03-19 |
2024-03-27 |
Regeneron Pharmaceuticals, Inc. |
Microchip capillary electrophoresis assays and reagents
|
|
US12253490B2
(en)
|
2018-03-19 |
2025-03-18 |
Regeneron Pharmaceuticals, Inc. |
Microchip capillary electrophoresis assays and reagents
|
|
TW202016125A
(zh)
|
2018-05-10 |
2020-05-01 |
美商再生元醫藥公司 |
用於定量及調節蛋白質黏度之系統與方法
|
|
US11690907B2
(en)
|
2018-06-12 |
2023-07-04 |
Kbio Holdings Limited |
Vaccines formed by virus and antigen conjugation
|
|
US11696948B2
(en)
|
2018-06-12 |
2023-07-11 |
Kbio Holdings Limited |
Vaccines formed by virus and antigen conjugation
|
|
CN110616198B
(zh)
*
|
2018-06-19 |
2021-02-19 |
清华大学 |
一种基于黑猩猩腺病毒68型和MERS-CoV全长膜蛋白的新型冠状病毒疫苗
|
|
TWI853823B
(zh)
|
2018-07-02 |
2024-09-01 |
美商里珍納龍藥品有限公司 |
自混合物製備多肽之系統及方法
|
|
KR102682192B1
(ko)
*
|
2018-08-17 |
2024-07-04 |
한림대학교 산학협력단 |
메르스 코로나바이러스 s 단백질에 대한 단클론 항체 및 그 용도
|
|
MY204234A
(en)
|
2018-08-27 |
2024-08-16 |
Regeneron Pharma |
Use of raman spectroscopy in downstream purification
|
|
BR112020026348A2
(pt)
|
2018-08-30 |
2021-03-30 |
Regeneron Pharmaceuticals, Inc. |
Método para avaliar a estequiometria e distribuição de tamanho de complexos de proteínas, para selecionar um medicamento de proteína principal e para caracterizar complexos de proteínas, e, composição farmacêutica
|
|
RU2709659C1
(ru)
*
|
2018-09-06 |
2019-12-19 |
федеральное государственное бюджетное учреждение "Национальный исследовательский центр эпидемиологии и микробиологии имени почетного академика Н.Ф. Гамалеи" Министерства здравоохранения Российской Федерации |
Иммунобиологическое средство и способ его использования для индукции специфического иммунитета к вирусу ближневосточного респираторного синдрома (варианты)
|
|
KR102007161B1
(ko)
*
|
2018-11-07 |
2019-08-07 |
대한민국 |
메르스 코로나 바이러스 스파이크 s1 단백질에 특이적으로 결합하는 단클론 항체
|
|
KR20210114927A
(ko)
|
2019-01-16 |
2021-09-24 |
리제너론 파마슈티칼스 인코포레이티드 |
이황화 결합을 특징 짓는 방법
|
|
EP3927432A2
(en)
*
|
2019-02-20 |
2021-12-29 |
Harbour Antibodies BV |
Antibodies
|
|
US11364276B2
(en)
|
2019-03-26 |
2022-06-21 |
National Guard Health Affairs |
Antiviral peptides for treatment of the middle east respiratory syndrome
|
|
PH12021500032A1
(en)
*
|
2019-04-03 |
2022-05-02 |
Regeneron Pharma |
Methods and compositions for insertion of antibody coding sequences into a safe harbor locus
|
|
KR102213745B1
(ko)
*
|
2019-04-16 |
2021-02-09 |
주식회사 바이오앱 |
돼지 유행성 설사병 바이러스 백신 조성물 및 이의 제조 방법
|
|
MX2021013519A
(es)
|
2019-05-13 |
2021-12-10 |
Regeneron Pharma |
Ensayos de union de ligandos competitivos mejorados.
|
|
WO2021060837A1
(en)
*
|
2019-09-23 |
2021-04-01 |
Seoul National University R&Db Foundation |
Anti-mers-cov antibody and use thereof
|
|
US12297451B1
(en)
|
2019-10-25 |
2025-05-13 |
Regeneron Pharmaceuticals, Inc. |
Cell culture medium
|
|
US11730793B2
(en)
|
2019-11-25 |
2023-08-22 |
Regeneron Pharmaceuticals, Inc. |
Sustained release formulations using non-aqueous emulsions
|
|
EP4354145B1
(en)
|
2020-01-21 |
2025-09-17 |
Regeneron Pharmaceuticals, Inc. |
Deglycosylation methods for electrophoresis of glycosylated proteins
|
|
KR20210095781A
(ko)
|
2020-01-24 |
2021-08-03 |
주식회사 에이프릴바이오 |
항원결합 단편 및 생리활성 이펙터 모이어티로 구성된 융합 컨스트럭트를 포함하는 다중결합항체 및 이를 포함하는 약학조성물
|
|
CN111592602B
(zh)
*
|
2020-02-10 |
2021-03-02 |
中国科学院微生物研究所 |
一种β冠状病毒抗原、其制备方法和应用
|
|
JP7772702B2
(ja)
|
2020-02-10 |
2025-11-18 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッド |
抗ｔｍｐｒｓｓ２抗体および抗原結合断片
|
|
HRP20231031T1
(hr)
|
2020-02-26 |
2023-12-22 |
Vir Biotechnology, Inc. |
Protutijela protiv sars-cov-2
|
|
CN113321713B
(zh)
*
|
2020-02-28 |
2022-11-01 |
深圳市亚辉龙生物科技股份有限公司 |
SARS-CoV-2的重组RBD蛋白及其制备方法
|
|
CA3171237A1
(en)
*
|
2020-03-09 |
2021-09-16 |
Kathryn WESTENDORF |
Anti-coronavirus antibodies and methods of use
|
|
WO2021183780A1
(en)
*
|
2020-03-11 |
2021-09-16 |
Ibio, Inc. |
Lichenase-covid-19 based vaccine
|
|
EP4117683A4
(en)
*
|
2020-03-12 |
2024-04-24 |
Sydney David Cullis-Hill |
Treatment for coronavirus infection and associated cytokine toxicity
|
|
WO2021207948A1
(en)
*
|
2020-04-14 |
2021-10-21 |
Tsb Therapeutics (Beijing) Co., Ltd. |
Anti-sars-cov-2 antibodies and uses thereof
|
|
US11365239B2
(en)
*
|
2020-03-20 |
2022-06-21 |
Tsb Therapeutics (Beijing) Co., Ltd. |
Anti-SARS-COV-2 antibodies and uses thereof
|
|
HRP20240182T1
(hr)
|
2020-03-26 |
2024-04-26 |
Vanderbilt University |
Ljudska monoklonska protutijela za teški akutni respiratorni sindrom koronavirusa 2 (sars-cov-2)
|
|
WO2021201679A1
(en)
|
2020-04-01 |
2021-10-07 |
Kiadis Pharma Intellectual Property B.V. |
Compositions and methods targeting coronaviruses
|
|
WO2021202650A1
(en)
*
|
2020-04-01 |
2021-10-07 |
Thiogenesis Therapeutics, Inc. |
Cysteamine precursor compounds for the treatment of betacoronavirus infections
|
|
WO2021045836A1
(en)
|
2020-04-02 |
2021-03-11 |
Regeneron Pharmaceuticals, Inc. |
Anti-sars-cov-2-spike glycoprotein antibodies and antigen-binding fragments
|
|
US20230399384A1
(en)
*
|
2020-04-24 |
2023-12-14 |
The Board Of Regents Of The University Of Texas System |
Antibodies to coronavirus spike protein and methods of use thereof
|
|
WO2021221043A1
(ja)
*
|
2020-04-30 |
2021-11-04 |
富士フイルム富山化学株式会社 |
ピラジン誘導体と他のコロナウイルス感染症治療薬とを組み合わせてなるコロナウイルス感染症治療剤
|
|
GB202007532D0
(en)
*
|
2020-05-20 |
2020-07-01 |
Alchemab Therapeutics Ltd |
Polypeptides
|
|
WO2021238910A1
(en)
*
|
2020-05-25 |
2021-12-02 |
Guo Bingshi |
Anti-coronavirus spike protein antibodies and uses thereof
|
|
CN116096745A
(zh)
|
2020-05-26 |
2023-05-09 |
瑞泽恩制药公司 |
抗sars-cov-2纤突糖蛋白抗体和抗原结合片段
|
|
CN111606981B
(zh)
*
|
2020-05-27 |
2022-02-08 |
中国医学科学院基础医学研究所 |
Sars-cov冠状病毒s1蛋白多肽及其应用
|
|
US11999777B2
(en)
*
|
2020-06-03 |
2024-06-04 |
Regeneron Pharmaceuticals, Inc. |
Methods for treating or preventing SARS-CoV-2 infections and COVID-19 with anti-SARS-CoV-2 spike glycoprotein antibodies
|
|
WO2021257695A2
(en)
*
|
2020-06-16 |
2021-12-23 |
Hifibio (Hk) Limited |
Methods and compositions related to neutralizing antibodies against human coronavirus
|
|
CA3183655A1
(en)
*
|
2020-06-23 |
2021-12-30 |
Mathias KAHL |
Binding protein specific for the spike protein of severe acute respiratory syndrome corona virus 2 (sars-cov-2)
|
|
US20250263468A1
(en)
*
|
2020-07-24 |
2025-08-21 |
Celltrion Inc. |
Binding molecule having neutralizing activity against coronavirus superfamily
|
|
WO2022026807A2
(en)
*
|
2020-07-30 |
2022-02-03 |
Albert Einstein College Of Medicine |
Antibodies targeting sars-cov-2 and uses thereof
|
|
WO2022031576A1
(en)
*
|
2020-08-03 |
2022-02-10 |
Janssen Biotech, Inc. |
Materials and methods for multidirectional biotransportation in virotherapeutics
|
|
US20230357365A1
(en)
*
|
2020-08-07 |
2023-11-09 |
Novelgen Co., Ltd. |
Antiviral composition against coronavirus
|
|
CA3192999A1
(en)
|
2020-08-31 |
2022-03-03 |
Regeneron Pharmaceuticals, Inc. |
Asparagine feed strategies to improve cell culture performance and mitigate asparagine sequence variants
|
|
WO2022054068A1
(en)
*
|
2020-09-14 |
2022-03-17 |
Ramot At Tel-Aviv University Ltd. |
Antibodies for the prevention, treatment and detection of coronavirus infection
|
|
CA3192706A1
(en)
*
|
2020-09-15 |
2022-03-24 |
Gregory SEMPOWSKI |
Coronavirus antibodies and uses thereof
|
|
US20230303666A1
(en)
*
|
2020-09-24 |
2023-09-28 |
The Broad Institute, Inc. |
Cell-free antibody engineering platform and neutralizing antibodies for sars-cov-2
|
|
CN112379087B
(zh)
*
|
2020-10-21 |
2022-02-11 |
中国医学科学院医学生物学研究所 |
一种应用于新型冠状病毒灭活疫苗的裂解液及抗原解离的方法
|
|
KR20230113280A
(ko)
|
2020-11-25 |
2023-07-28 |
리제너론 파마슈티칼스 인코포레이티드 |
비수성 멤브레인 유화법을 사용한 지속 방출 제형
|
|
CN116710124A
(zh)
|
2020-12-17 |
2023-09-05 |
瑞泽恩制药公司 |
包封蛋白质的微凝胶的制造
|
|
CN114716541B
(zh)
*
|
2021-01-05 |
2023-07-21 |
中国科学院分子细胞科学卓越创新中心 |
抗冠状病毒的全人广谱中和抗体76e1及其应用
|
|
US11834493B2
(en)
|
2021-01-05 |
2023-12-05 |
Immunome, Inc. |
Antibody cocktail against SARS-CoV-2 spike protein
|
|
US12031151B2
(en)
|
2021-01-20 |
2024-07-09 |
Regeneron Pharmaceuticals, Inc. |
Methods of improving protein titer in cell culture
|
|
US20240101645A1
(en)
*
|
2021-01-22 |
2024-03-28 |
The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. |
Monoclonal antibodies against coronaviruses and uses thereof
|
|
WO2022170126A2
(en)
*
|
2021-02-05 |
2022-08-11 |
Adagio Therapeutics, Inc. |
Compounds specific to coronavirus s protein and uses thereof
|
|
WO2022182662A1
(en)
|
2021-02-23 |
2022-09-01 |
10X Genomics, Inc. |
Compositions and methods for mapping antigen-binding molecule affinity to antigen regions of interest
|
|
KR20230154020A
(ko)
*
|
2021-03-02 |
2023-11-07 |
노바록 바이오테라퓨틱스 리미티드 |
클라우딘-6에 대한 항체 및 이의 용도
|
|
AR125585A1
(es)
|
2021-03-03 |
2023-08-02 |
Regeneron Pharma |
Sistemas y métodos para cuantificar y modificar la viscosidad de proteínas
|
|
WO2022187626A1
(en)
|
2021-03-05 |
2022-09-09 |
Regeneron Pharmaceuticals, Inc. |
Anti-sars-cov-2-variant-spike glycoprotein antibodies and antigen-binding fragments
|
|
WO2022197664A1
(en)
*
|
2021-03-15 |
2022-09-22 |
Emory University |
Sars-cov-2 antibodies and fragments, therapeutic uses, diagnostic uses, and compositions related thereto
|
|
WO2022212654A2
(en)
*
|
2021-04-02 |
2022-10-06 |
The Scripps Research Institute |
Cross-reactive monoclonal antibodies against coronaviruses
|
|
WO2022241200A1
(en)
*
|
2021-05-14 |
2022-11-17 |
Vanderbilt University |
Cross-reactive coronavirus antibodies
|
|
CA3220848A1
(en)
|
2021-06-01 |
2022-12-08 |
Timothy Riehlman |
Microchip capillary electrophoresis assays and reagents
|
|
AU2022311906A1
(en)
|
2021-07-14 |
2024-01-25 |
Regeneron Pharmaceuticals, Inc. |
Anti-sars-cov-2-spike glycoprotein antibodies and antigen-binding fragments
|
|
KR20240046926A
(ko)
*
|
2021-07-23 |
2024-04-11 |
더 트러스티스 오브 컬럼비아 유니버시티 인 더 시티 오브 뉴욕 |
Sars-cov-2, 그 변이체 및 관련 코로나바이러스를 강력하고 광범위하게 중화하는 단일클론항체의 특성 분석 및 사용 방법
|
|
TW202326138A
(zh)
|
2021-09-08 |
2023-07-01 |
美商再生元醫藥公司 |
用於定量抗體及其他含Ｆｃ蛋白之高通量及基於質譜之方法
|
|
JP2024531800A
(ja)
|
2021-09-20 |
2024-08-29 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッド |
抗体の不均一性を制御する方法
|
|
CN116178530A
(zh)
*
|
2021-09-26 |
2023-05-30 |
上海君实生物医药科技股份有限公司 |
抗体在治疗SARS-CoV-2感染的用途
|
|
TW202323817A
(zh)
|
2021-10-07 |
2023-06-16 |
美商再生元醫藥公司 |
Ｐｈ建模及控制之系統及方法
|
|
KR20240090312A
(ko)
|
2021-10-07 |
2024-06-21 |
리제너론 파아마슈티컬스, 인크. |
Ph 미터 보정 및 교정
|
|
WO2023244276A2
(en)
*
|
2021-10-13 |
2023-12-21 |
The Wistar Institute Of Anatomy And Biology |
DNA ENCODED ANTIBODIES WITH Fc MODIFICATIONS
|
|
CA3236367A1
(en)
|
2021-10-26 |
2023-05-04 |
Michelle Lafond |
Systems and methods for generating laboratory water and distributing laboratory water at different temperatures
|
|
TW202342510A
(zh)
|
2022-02-18 |
2023-11-01 |
英商Ｒｑ生物科技有限公司 |
抗體
|
|
WO2023178182A1
(en)
|
2022-03-16 |
2023-09-21 |
10X Genomics, Inc. |
Compositions and methods for detection and treatment of coronavirus infection
|
|
TW202445126A
(zh)
|
2023-01-25 |
2024-11-16 |
美商再生元醫藥公司 |
基於質譜法之體內共表現抗體之表徵
|
|
US20240245779A1
(en)
|
2023-01-25 |
2024-07-25 |
Regeneron Pharmaceuticals, Inc. |
Methods of modeling liquid protein composition stability
|
|
TW202445138A
(zh)
|
2023-02-01 |
2024-11-16 |
美商再生元醫藥公司 |
用於生物巨分子分析之具質譜法的不對稱流場流分離
|
|
TW202446462A
(zh)
|
2023-02-22 |
2024-12-01 |
美商再生元醫藥公司 |
系統適用性參數及管柱老化
|
|
TW202508625A
(zh)
|
2023-05-01 |
2025-03-01 |
美商再生元醫藥公司 |
使用苯酚或苯甲醇之多劑量抗體藥物產品
|
|
WO2025072597A2
(en)
|
2023-09-29 |
2025-04-03 |
Regeneron Pharmaceuticals, Inc. |
Lyophilization using controlled nucleation
|
|
US20250129117A1
(en)
|
2023-10-18 |
2025-04-24 |
Regeneron Pharmaceuticals, Inc. |
Rapid purification of monoclonal antibody from in-process upstream cell culture material
|
|
WO2025096932A1
(en)
|
2023-11-02 |
2025-05-08 |
Regeneron Pharmaceuticals, Inc. |
Methods for reducing lipase activity using stress
|
|
WO2025166281A1
(en)
|
2024-02-01 |
2025-08-07 |
Regeneron Pharmaceuticals, Inc. |
Platform for charge-detection mass spectrometry analysis of aavs
|
|
WO2025175164A1
(en)
|
2024-02-16 |
2025-08-21 |
Regeneron Pharmaceuticals, Inc. |
Methods of producing concentrated formulated drug substances comprising proteins, and concentrated formulated drug substance made by the methods
|
|
WO2025194043A1
(en)
|
2024-03-15 |
2025-09-18 |
Regeneron Pharmaceuticals, Inc. |
Polysorbate and polyoxyethylene sorbitan as excipients for stable protein formulations
|
|
CN119264262B
(zh)
*
|
2024-09-19 |
2025-09-02 |
中山大学 |
一种双特异性抗体及其应用
|